Too Much Acetaminophen Could Harm Seniors' Health
By Robin Foster HealthDay Reporter
TUESDAY, Dec. 24, 2024 -- New British research shows that too much of a good medication can be a bad thing.
In the study, repeated doses of paracetamol, known as acetaminophen (brand name Tylenol) in the United States, raised the risk of gastrointestinal, cardiovascular and kidney complications among those over 65.
The findings, published recently in the journal Arthritis Care and Research, illustrate the dangers of older people taking too much of the painkiller for chronic, painful conditions such as osteoarthritis.
Acetaminophen is used to temporarily relieve mild to moderate pain and fever. It is commonly included as an ingredient in cold and flu medications and is also taken on its own. It works by blocking signals in the brain that let people know when they're in pain and by affecting the chemicals that regulate their body temperature.
Evidence also suggests the widely used painkiller inhibits the production of prostaglandins, which are made by the body to deal with illness and injury.
Weiya Zhang, from the NIHR Biomedical Research Centre in the School of Medicine at the University of Nottingham, led the study.
"Due to its perceived safety, paracetamol [acetaminophen] has long been recommended as the first-line drug treatment for osteoarthritis by many treatment guidelines, especially in older people who are at higher risk of drug-related complications," Zhang noted in a university news release.
In the study, researchers analyzed data on over 180,400 people aged 65 and over who had been prescribed acetaminophen repeatedly (more than twice within six months).
Their health was then compared to nearly 402,500 people of the same age who had never been prescribed the drug repeatedly.
What did they discover?
The findings showed that prolonged acetaminophen use was associated with an increased risk of gastrointestinal bleeding (36%); peptic ulcers (20%); heart failure (9%); hypertension (7%); and chronic kidney disease (19%).
“Whilst further research is now needed to confirm our findings, given its minimal pain-relief effect, the use of paracetamol as a first-line painkiller for long-term conditions such as osteoarthritis in older people needs to be carefully considered,” Zhang said.
Sources
- University of Nottingham, news release, Dec. 12, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Ex-Vaccine Panelist Speaks Out on Firing, New Committee
Thursday, June 26, 2025 — The federal Advisory Committee on Immunization Practices (ACIP) has been soberly and deliberately helping set U.S. vaccination policy for more than...
Senate Grills CDC Nominee Susan Monarez on Agency Cuts
THURSDAY, June 26, 2025 — The woman tapped to lead the U.S. Centers for Disease Control and Prevention (CDC) says she supports science, vaccines and public health...
NIH Stops Canceling Research Grants Following Court Ruling
THURSDAY, June 26, 2025 — The National Institutes of Health (NIH) has stopped canceling biomedical research grants after a federal judge said hundreds of those cuts were...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.